According to Lung Kee Group Holdings Limited’s latest filing, the authorized share capital remained unchanged as of 30 November 2025. The company continues to register 1,000,000,000 ordinary shares at a par value of HKD0.1 each, totaling HKD100,000,000.

The number of issued shares (excluding treasury shares) increased from 632,387,303 shares to 633,257,303 shares, an increase of 870,000 shares. The increase resulted from exercises of share options under the company’s Share Option Schemes, generating HKD1,189,780 in proceeds during the month.

Among the reported Share Option Schemes, 410,000 shares were exercised from the scheme granted on 28 September 2023 (exercise price HKD1.578) and 460,000 shares were exercised from the scheme granted on 27 September 2024 (exercise price HKD1.18). Another scheme granted on 18 September 2025, with an exercise price of HKD1.66, had no shares exercised in November 2025. The total issued shares thus reached 633,257,303 by month-end, with no treasury shares reported.